Home/Authera/Jan Terje Andersen
JT

Jan Terje Andersen

Chairman of the Board & Co-founder

Authera

Roles

Chairman of the Board & Co-founderatAuthera
Chairman & Co-founderatAuthera

Therapeutic Areas

Authera Pipeline

DrugIndicationPhase
AuT-1Exudative eye diseases (e.g., wet AMD, diabetic macular edema)Pre-clinical
Undisclosed PipelineNot Specified (FcRn biology-based)Pre-clinical
UndisclosedNot SpecifiedPre-clinical